Piper Sandler Maintains Neutral on Core Laboratories, Lowers Price Target to $17
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Luke Lemoine maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $18 to $17.
Piper Sandler analyst Luke Lemoine maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $18 to $17.